SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950172-24-000139
Filing Date
2024-03-28
Accepted
2024-03-28 12:39:13
Documents
1
Period of Report
2024-03-25

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3360
  Complete submission text file 0000950172-24-000139.txt   4759
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Issuer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4218 ROCKRIDGE ROAD WEST VANCOUVER A1 V7M 1A4
Business Address
Sollis Gary (Reporting) CIK: 0001826324 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37410 | Film No.: 24796561